-
Loading metrics
Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models
- Raza Jamal,
- Jonathan LaCombe,
- Roshni Patel,
- Matthew Blackwell,
- Jared R. Thomas,
- Kourtney Sloan,
- Joseph M. Wallace,
- Randall J. Roper
x
- Published: February 23, 2022
- https://doi.org/10.1371/journal.pone.0264254